2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guide...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiac failure Vol. 28; no. 5; p. e1
Format Journal Article
LanguageEnglish
Published United States 01.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
AbstractList The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.AIMThe "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.METHODSA comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021.Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.STRUCTUREHeart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35378257$$D View this record in MEDLINE/PubMed
BookMark eNpNT0tLxDAYDLLiPvQvLDl6aTdJkyZ7klLsVljxoJ5LmnzRLn2Ztgf__VZcQRiYOcyDWaNF27WA0JaSkBIa706h0d46XdUhI4yFZAYlV2hFRcQCxSlf_NNLtB6GEyFEcSJv0DISkVRMyBV6-EnjJE92SZru8uw1wYepslBXLWDXeTx-An7Wrf6ABtoRdw7noP2Is3l68nCLrp2uB7i78Aa9Z49vaR4cXw5PaXIMekbpGBjFnYyMpAqE1CyWnMclJ9YJa0pihaKcgxFQggEGe6MVUFGqPWinrCY22qD7397ed18TDGPRVIOButYtdNNQsJhLRplU-9m6vVinsgFb9L5qtP8u_k5HZwCqWuI
ContentType Journal Article
Contributor Kittleson, Michelle M
Dunlay, Shannon M
Sandhu, Alexander T
Vest, Amanda R
Woo, Y Joseph
Heidenreich, Paul A
Gentile, Federico
Dixon, Dave L
Wijeysundera, Duminda N
Hernandez, Adrian F
Milano, Carmelo A
Allen, Larry A
O'Gara, Patrick T
Goldberger, Zachary D
Al-Khatib, Sana M
Cigarroa, Joaquin E
Piano, Mariann R
Hayek, Salim S
Nnacheta, Lorraine C
Deswal, Anita
Tamis-Holland, Jacqueline E
Byun, Joni J
Stevenson, Lynne Warner
Bozkurt, Biykem
Spatz, Erica S
Fedson, Savitri E
Khazanie, Prateeti
Mark, Daniel B
Aguilar, David
Lee, Christopher S
Colvin, Monica M
Palaniappan, Latha P
Beckman, Joshua A
Marine, Joseph E
Hlatky, Mark A
Joglar, José A
Haynes, Norrisa
Link, Mark S
Armbruster, Anastasia L
Fleisher, Lee A
Yancy, Clyde W
Evers, Linda R
Gorenek, Bulent
Mukherjee, Debabrata
Fang, James C
Fonarow, Gregg C
Drazner, Mark H
Birtcher, Kim K
Jones, W Schuyler
Vardeny, Orly
de las Fuentes, Lisa
Rab, Tanveer
Contributor_xml – sequence: 1
  givenname: Paul A
  surname: Heidenreich
  fullname: Heidenreich, Paul A
– sequence: 2
  givenname: Biykem
  surname: Bozkurt
  fullname: Bozkurt, Biykem
– sequence: 3
  givenname: David
  surname: Aguilar
  fullname: Aguilar, David
– sequence: 4
  givenname: Larry A
  surname: Allen
  fullname: Allen, Larry A
– sequence: 5
  givenname: Joni J
  surname: Byun
  fullname: Byun, Joni J
– sequence: 6
  givenname: Monica M
  surname: Colvin
  fullname: Colvin, Monica M
– sequence: 7
  givenname: Anita
  surname: Deswal
  fullname: Deswal, Anita
– sequence: 8
  givenname: Mark H
  surname: Drazner
  fullname: Drazner, Mark H
– sequence: 9
  givenname: Shannon M
  surname: Dunlay
  fullname: Dunlay, Shannon M
– sequence: 10
  givenname: Linda R
  surname: Evers
  fullname: Evers, Linda R
– sequence: 11
  givenname: James C
  surname: Fang
  fullname: Fang, James C
– sequence: 12
  givenname: Savitri E
  surname: Fedson
  fullname: Fedson, Savitri E
– sequence: 13
  givenname: Gregg C
  surname: Fonarow
  fullname: Fonarow, Gregg C
– sequence: 14
  givenname: Salim S
  surname: Hayek
  fullname: Hayek, Salim S
– sequence: 15
  givenname: Adrian F
  surname: Hernandez
  fullname: Hernandez, Adrian F
– sequence: 16
  givenname: Prateeti
  surname: Khazanie
  fullname: Khazanie, Prateeti
– sequence: 17
  givenname: Michelle M
  surname: Kittleson
  fullname: Kittleson, Michelle M
– sequence: 18
  givenname: Christopher S
  surname: Lee
  fullname: Lee, Christopher S
– sequence: 19
  givenname: Mark S
  surname: Link
  fullname: Link, Mark S
– sequence: 20
  givenname: Carmelo A
  surname: Milano
  fullname: Milano, Carmelo A
– sequence: 21
  givenname: Lorraine C
  surname: Nnacheta
  fullname: Nnacheta, Lorraine C
– sequence: 22
  givenname: Alexander T
  surname: Sandhu
  fullname: Sandhu, Alexander T
– sequence: 23
  givenname: Lynne Warner
  surname: Stevenson
  fullname: Stevenson, Lynne Warner
– sequence: 24
  givenname: Orly
  surname: Vardeny
  fullname: Vardeny, Orly
– sequence: 25
  givenname: Amanda R
  surname: Vest
  fullname: Vest, Amanda R
– sequence: 26
  givenname: Clyde W
  surname: Yancy
  fullname: Yancy, Clyde W
– sequence: 27
  givenname: Joshua A
  surname: Beckman
  fullname: Beckman, Joshua A
– sequence: 28
  givenname: Patrick T
  surname: O'Gara
  fullname: O'Gara, Patrick T
– sequence: 29
  givenname: Sana M
  surname: Al-Khatib
  fullname: Al-Khatib, Sana M
– sequence: 30
  givenname: Anastasia L
  surname: Armbruster
  fullname: Armbruster, Anastasia L
– sequence: 31
  givenname: Kim K
  surname: Birtcher
  fullname: Birtcher, Kim K
– sequence: 32
  givenname: Joaquin E
  surname: Cigarroa
  fullname: Cigarroa, Joaquin E
– sequence: 33
  givenname: Lisa
  surname: de las Fuentes
  fullname: de las Fuentes, Lisa
– sequence: 34
  givenname: Dave L
  surname: Dixon
  fullname: Dixon, Dave L
– sequence: 35
  givenname: Lee A
  surname: Fleisher
  fullname: Fleisher, Lee A
– sequence: 36
  givenname: Federico
  surname: Gentile
  fullname: Gentile, Federico
– sequence: 37
  givenname: Zachary D
  surname: Goldberger
  fullname: Goldberger, Zachary D
– sequence: 38
  givenname: Bulent
  surname: Gorenek
  fullname: Gorenek, Bulent
– sequence: 39
  givenname: Norrisa
  surname: Haynes
  fullname: Haynes, Norrisa
– sequence: 40
  givenname: Mark A
  surname: Hlatky
  fullname: Hlatky, Mark A
– sequence: 41
  givenname: José A
  surname: Joglar
  fullname: Joglar, José A
– sequence: 42
  givenname: W Schuyler
  surname: Jones
  fullname: Jones, W Schuyler
– sequence: 43
  givenname: Joseph E
  surname: Marine
  fullname: Marine, Joseph E
– sequence: 44
  givenname: Daniel B
  surname: Mark
  fullname: Mark, Daniel B
– sequence: 45
  givenname: Debabrata
  surname: Mukherjee
  fullname: Mukherjee, Debabrata
– sequence: 46
  givenname: Latha P
  surname: Palaniappan
  fullname: Palaniappan, Latha P
– sequence: 47
  givenname: Mariann R
  surname: Piano
  fullname: Piano, Mariann R
– sequence: 48
  givenname: Tanveer
  surname: Rab
  fullname: Rab, Tanveer
– sequence: 49
  givenname: Erica S
  surname: Spatz
  fullname: Spatz, Erica S
– sequence: 50
  givenname: Jacqueline E
  surname: Tamis-Holland
  fullname: Tamis-Holland, Jacqueline E
– sequence: 51
  givenname: Duminda N
  surname: Wijeysundera
  fullname: Wijeysundera, Duminda N
– sequence: 52
  givenname: Y Joseph
  surname: Woo
  fullname: Woo, Y Joseph
Copyright Copyright © 2021 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 Elsevier Inc. All rights reserved.
CorporateAuthor Writing Committee Members
ACC/AHA Joint Committee Members
CorporateAuthor_xml – name: ACC/AHA Joint Committee Members
– name: Writing Committee Members
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.cardfail.2022.02.010
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-8414
ExternalDocumentID 35378257
Genre Journal Article
Practice Guideline
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CGR
COF
CS3
CUY
CVF
DU5
EBS
ECM
EFJIC
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
M29
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OA~
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UHS
WUQ
Z5R
~G-
7X8
AAYWO
ACIEU
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
APXCP
EFKBS
ID FETCH-LOGICAL-p211t-c84f73c718e57a267446b40df5dcb0d58144ec5ebece2e9ca8e15b89eaf8da0d3
ISSN 1532-8414
IngestDate Tue Aug 05 09:48:22 EDT 2025
Thu Apr 03 07:01:07 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2021 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-c84f73c718e57a267446b40df5dcb0d58144ec5ebece2e9ca8e15b89eaf8da0d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
PMID 35378257
PQID 2647212789
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2647212789
pubmed_primary_35378257
PublicationCentury 2000
PublicationDate 2022-May
20220501
PublicationDateYYYYMMDD 2022-05-01
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-May
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of cardiac failure
PublicationTitleAlternate J Card Fail
PublicationYear 2022
SSID ssj0008407
Score 2.6888807
Snippet The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage e1
SubjectTerms American Heart Association
Cardiology
Heart Failure - drug therapy
Heart Failure - therapy
Humans
Research Report
United States - epidemiology
Title 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
URI https://www.ncbi.nlm.nih.gov/pubmed/35378257
https://www.proquest.com/docview/2647212789
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bS8MwFMeDbiC-iHfnjQi-jc6tTXp5klJWhmxTtIO9laRJQZFtaPfip_ekzboKFaYvoYStDfmlJ-e05_yL0C34rMLyGDO42WUGcYVteDahBrMhlmCcdUUu1zQa24MJeZjS6VrNIq8uyXgn-aqtK_kPVegDrqpK9g9ky5NCBxwDX2iBMLQbMTZha2z7A1-JIgQBtIPwxQfqSrpKeY-rFMJ1jkv-3B4Wd9YO2eu7VhOpcU6TfOEk7bTyK_1sAMLKMhOvNGdg70hRptmRNX3aBppuhTWtGDTZq7WzRcj_1lGjUSPpqKvn4qc6SfWHsPX4MQ4nw2Ec9afRNmqa4NGbDdT0g-fhU7ltQqTpFOK2xfAq5dz11_k9Jsh9g2gf7el5w35B6ABtydkh2hnptIUjdK_OhwHUHWC6U5BwCQkDJAyQ8BoSnqc4h4Q1pGM0CftRMDD0lyuMBQTUmZG4JHWsBPZ9SR1m2g4E3Zx0RUpFwruCuhDGyoSqG0ia0kuYK3uUu55kqSvU_XGCGrP5TJ4hTFzb5innnFBJiHA8KS0p4JinzBKO00I3q1mIwTKo1z1sJufLz9hUXwboqUrnFjotpideFBImsUUtcA2pc77Bvy_Q7nptXaJG9rGUV-CJZfxaM_wGBqgwLQ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2022+AHA%2FACC%2FHFSA+Guideline+for+the+Management+of+Heart+Failure&rft.jtitle=Journal+of+cardiac+failure&rft.date=2022-05-01&rft.issn=1532-8414&rft.eissn=1532-8414&rft.volume=28&rft.issue=5&rft.spage=e1&rft_id=info:doi/10.1016%2Fj.cardfail.2022.02.010&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1532-8414&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1532-8414&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1532-8414&client=summon